Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Lilly's Alzheimer's Gamble Aims at $10 Billion Patent Loss
Bloomberg
Tuesday, July 13, 2010 - 8:39am
tags:
Eli Lilly, Alzheimer's disease, semagacestat, solanezumab
Key Vytorin Exec Has Left Merck
Forbes
Tuesday, July 13, 2010 - 8:38am
tags:
Vytorin, Merck, Schering Plough
Six Reasons Avandia Could Stay On the Market
Forbes
Tuesday, July 13, 2010 - 8:37am
tags:
GSK, FDA, diabetes, Avandia
Biotech start-up wins Google's attention--and money
Fierce Biotech
Monday, July 12, 2010 - 2:40pm
tags:
biotech, start-ups, financing, Google, iPierian
Why the FDA Will Likely Reject 3 New Weight Loss Drugs
BNET Pharma
Monday, July 12, 2010 - 2:39pm
tags:
FDA, Vivus, obesity, Qnexa, Orexigen, Arena Pharmaceuticals, Contrave
Drug Pipeline Pulse Check: High Expectations for Novartis
Seeking Alpha
Monday, July 12, 2010 - 2:38pm
tags:
Novartis, Genzyme, Novelos Therapeutics, Alcon
Bristol-Myers Squibb starts recall of Coumadin
Yahoo/AP
Monday, July 12, 2010 - 2:36pm
tags:
recalls, Coumadin, Bristol-Myers Squibb
Former FDA Reviewers Says Glaxo Withheld Study
Pharmalot
Monday, July 12, 2010 - 2:35pm
tags:
GSK, Avandia, diabetes, FDA
Gilead Sciences: Undervalued
Seeking Alpha
Monday, July 12, 2010 - 2:34pm
tags:
Gilead Sciences, Merck, JNJ, Vertex Pharmaceuticals
PhRMA not interested in free-sample limits
Fierce Pharma
Monday, July 12, 2010 - 10:54am
tags:
PhRMA, samples, free sample limits, Europe
Biogen says hemophilia drug meets safety goal
Yahoo/AP
Monday, July 12, 2010 - 10:52am
tags:
Biogen Idec, hemophilia, Biovitrum
Kamada: Wise Strategy or Overly Ambitious?
Seeking Alpha
Monday, July 12, 2010 - 10:41am
tags:
Kamada, Talecris, Glassia
Avandia, Qnexa Mean a Big Week for FDA Advisory Committee
WSJ Online
Monday, July 12, 2010 - 10:24am
tags:
Qnexa, Avandia, FDA, GSK, diabetes, obesity, advisory panels, Vivus
Glaxo shares inch higher ahead of FDA meeting
Marketwatch
Monday, July 12, 2010 - 10:21am
tags:
GSK, FDA, Avandia, advisory panels
Sanofi looks to sell EU research sites to Covance
Outsourcing Pharma
Monday, July 12, 2010 - 10:16am
tags:
Sanofi, Covance, Europe
4-Star Stocks Poised to Pop: Abbott Labs
Motley Fool
Monday, July 12, 2010 - 10:15am
tags:
Abbott Laboratories
Three Things To Remember During The Avandia Panel
Forbes
Monday, July 12, 2010 - 10:14am
tags:
GSK, FDA, Avandia, diabetes, advisory panels
J&J to buy Micrus Endovascular for $480 million
Marketwatch
Monday, July 12, 2010 - 10:12am
tags:
Micrus Endovascular, JNJ, M&A
Don't push big pharma off a cliff just yet
Investment News
Sunday, July 11, 2010 - 2:42pm
tags:
Big Pharma, patents, Eli Lilly, Zyprexa, Plavix, Bristol-Myers Squibb, Pfizer, Lipitor, Merck, Singulair
J&J Sued by Consumers Over Children's Cold Medicines
Bloomberg
Sunday, July 11, 2010 - 2:40pm
tags:
JNJ, lawsuits, consumers, recalls

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.